Residual risk for coronary heart disease events and mortality despite intensive medical management after myocardial infarction

High-intensity statins, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and antiplatelet agents (ie, intensive medical management) reduce coronary heart disease (CHD) risk after myocardial infarction (MI).

Source: Journal of Clinical Lipidology - January 22, 2020 Category: Lipidology Authors: Todd M. Brown, Vera Bittner, Lisandro D. Colantonio, Luqin Deng, Michael E. Farkouh, Nita Limdi, Keri L. Monda, Robert S. Rosenson, Maria-Corina Serban, Ransi M. Somaratne, Hong Zhao, Mark Woodward, Paul Muntner Tags: Original Article Source Type: research